Two patients with nonimmune chronic idiopathic neutropenia of adults developing acute myeloid leukemia with aberrant phenotype and complex karyotype but no mutations in granulocyte colony-stimulating factor receptor

• Published in: Annals of hematology 2002, Vol.81 (1), p.50-54
• Main Authors: PAPADAKI, H. A, KOSTEAS, T, GEMETZI, C, ALEXANDRAKIS, M, PSYLLAKI, M, ELIOPOULOS, G. D
• Format: Article
• Language: English
• Subjects: Acute Disease; Acute myeloid leukemia; Adult; Biological and medical sciences; Bone marrow; CD19 antigen; CD56 antigen; CD7 antigen; Cell surface; Chemotherapy; Chronic Disease; Erythema nodosum; Female; Granulocyte colony-stimulating factor; Granulocyte colony-stimulating factor receptors; Hematologic and hematopoietic diseases; Humans; Joints; Karyotypes; Karyotyping; Leukemia, Myeloid - etiology; Leukemia, Myeloid - genetics; Leukemia, Myeloid - pathology; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; Medical sciences; Middle Aged; Mutation; Natural killer cells; Neutropenia; Neutropenia - complications; Polyarthritis; Receptors, Granulocyte Colony-Stimulating Factor - genetics; Remission
• ISSN: 0939-5555; 1432-0584
• DOI: 10.1007/s00277-001-0401-z

It has been suggested that some cases of nonimmune chronic idiopathic neutropenia of adults (NI-CINA) may be considered preleukemic disorders. This paper describes two patients with NI-CINA who developed acute myeloid leukemia (AML) 34 and 64 months, respectively, following NI-CINA diagnosis. Patient 1 presented erythema nodosum and patient 2 polyarthritis of the large joints 9 and 2 months, respectively, before AML. Patient 1 had AML M4 disease associated with aberrant expression of CD7 and CD19 cell surface markers and one abnormal clone in bone marrow karyotype. Patient 2 had myeloid/natural killer (NK) cell leukemia with expression of CD7 and CD56 molecules and four derivative abnormal clones in the karyotype. Both patients had del(5)(q22q35) in common. No mutations in the transmembrane or the intracytoplasmic domain of the granulocyte colony-stimulating factor (G-CSF) receptor were found. The first patient had disease resistant to chemotherapy from the beginning of the treatment and the second following a brief complete hematological remission. On the basis of these observations, we concluded that a causal link of AML with the underlying NI-CINA cannot be presently justified, but the unusual findings noted in our patients prompt the description of additional cases for a further investigation of the relationships, if any, between these two granulocytic disorders.